Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468

Lancet. 1989 Jun 24;1(8652):1445-6. doi: 10.1016/s0140-6736(89)90146-3.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Dopamine Agents / administration & dosage*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Indoles / administration & dosage*
  • Levodopa / administration & dosage
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Pilot Projects

Substances

  • Dopamine Agents
  • Indoles
  • ropinirole
  • Levodopa